-
effectivehealthcare.ahrq.gov/sites/default/files/medical-test-reviews-genetic.ppt
June 01, 2012 - term=16144894
The ability of providers to accurately determine a family history that indicates increased
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/medical-test-reviews-genetic.ppt
June 01, 2012 - term=16144894
The ability of providers to accurately determine a family history that indicates increased
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/progestogens-preterm-birth-disposition-121205.pdf
September 07, 2012 - Moderate strength of evidence
indicates lack of effectiveness for multiple
gestations. … (Check with KH)
Peer Reviewer #8 Results Table 10 on page 43: To be consistent, the * that indicates … Peer Reviewer #8 Results Table 10, page 43: The text indicates that the mean GA
difference in the Borna … 82, Table 22: Rating reconsideration, Threatened Preterm
Labor: The aggregated result of 3 trials indicates … However, it should be made clear that
the data as it stands indicates the success of a particular
progestogen
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/recombinant-factor-viia_disposition-comments.pdf
June 01, 2010 - Examination of the dosing information
also indicates substantial variation in the dose of rFVIIa
dispensed … Examination of
the dosing information also indicates substantial variation in the
dose of rFVIIa dispensed … (page 62) The presentation of
information on this subset of hospitals indicates the extreme
variation … The “Applicability” paragraph indicates that the
inclusion of patients with isolated traumatic brain
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/rheumatoid-arthritis-hospitalizations_research.pdf
October 01, 2008 - prevalence and the specificity of the
definitions7, and when disease prevalence is low, a high PPV indicates … Opportunistic mycoses 117.3, 518.6, 484.6, 112.4, 112.5, 112.81, 112.83,
112.84, 114*, 117.5, 321.0 and 115*
*Indicates
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-201-indoor-allergen-reduction-asthma-evidence-summary.pdf
February 01, 2018 - instruments)
Indoor allergen levels
(Secondary measure)
KQ1
KQ1 KQ1
KQ=Key Question
Dashed line indicates
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-abnormalities-tests_executive.pdf
February 01, 2006 - Issues
There was insufficient evidence to estimate how
accurate these tests are in women whose
mammogram indicates
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/rfviia.pptx
May 01, 2010 - *ICH = intracranial hemorrhage here—although in rest of report “ICH” indicates a subset of intracranial
-
effectivehealthcare.ahrq.gov/sites/default/files/rfviia.pptx
May 01, 2010 - *ICH = intracranial hemorrhage here—although in rest of report “ICH” indicates a subset of intracranial
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/dietary-protein-intake-executive-summary.pdf
November 01, 2024 - Executive summary_Evaluation of Dietary Protein and Amino Acid Requirements: A Systematic Review
Systematic Review
Evaluation of Dietary Protein and Amino
Acid Requirements: A Systematic Review
Executive Summary
Main Points
Background and Purpose
Protein is essential for the growth, developm…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/kidney-stone-prevention_research-protocol.pdf
June 15, 2011 - A rating of
good generally indicates that the trial reported adequate allocation concealment, blinding … Statistical heterogeneity will be summarized by using the I
2
statistic (50 percent indicates moderate … heterogeneity and 75 percent or greater indicates high
heterogeneity
34
).
13
Source: www.effectivehealthcare.ahrq.gov
-
effectivehealthcare.ahrq.gov/sites/default/files/cer-238-cervical-ripening-appendix-e-1.xlsx
January 01, 2009 - criteria, but then later on hypertension was stated to be one of the primary indications for IOL, which indicates
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/radiotherapy-proton-beam_research.pdf
May 01, 2012 - Proton beam radiotherapy is a form of external beam radiation
that offers better precision for localized dosage than other types
of external beam radiotherapy. Because proton beams deposit
most of their energy during the final portion of their trajectory,
they diminish the risk of damage to tissue surrounding the t…
-
effectivehealthcare.ahrq.gov/sites/default/files/ch_5-user-guide-to-ocer_130129.pdf
January 01, 2012 - 59
Abstract
This chapter discusses considerations for comparator selection in observational comparative effectiveness
research (CER). Comparison groups should reflect clinically meaningful choices in real world practice
and be chosen based on the study question being addressed. Recognizing the implications and pote…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/wheelchair-users-amended-protocol.pdf
June 21, 2019 - Department of Health and Human Services indicates that routine
physical activity programs combining … PICOTS—
Inclusion and
exclusion criteria,
Page 8, Study
designs, Inclusion
The original
protocol indicates … Careful
review of the SCI
studies indicates
there is a paucity
of studies
conducted with
larger … published prior to
2009
The proposed edit
is “Studies
published before
2008”
This more clearly
indicates
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-drugs-utilization_research.pdf
January 01, 2011 - Utilization of anticancer biologic products among
Medicare beneficiaries, by diagnostic cancer subchapter,
2006-2009
Anticancer Biologics Data Points #7
Fewer than 50 percent of
beneficiaries with bevacizumab
orders had a cancer diagnosis
in the prior 6 months. This was
driven by the biologic’s off-label
use …
-
effectivehealthcare.ahrq.gov/sites/default/files/comparator-selection-in-observational-chapter-5.pptx
January 01, 2013 - Slide 1
Comparator Selection in Observational Comparative Effectiveness Research
Prepared for:
Agency for Healthcare Research and Quality (AHRQ)
www.ahrq.gov
Comparator Selection in Observational Comparative Effectiveness Research
This slide set is based on a user guide titled Developing a Protocol for Observation…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/recombinant-factor-viia_executive.pdf
May 01, 2010 - Layout 1
Background
This report evaluates the level of evidence
currently available to support the
effectiveness and safety of using
recombinant activated coagulation factor
VII (rFVIIa) for clinical indications not
approved by the U. S. Food and Drug
Administration (FDA). rFVIIa is approved
for a variety of uses i…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/updating-criteria-qdr-protocol-amendment.pdf
December 28, 2023 - Updating the Measurement Criteria for AHRQ’s National Healthcare Quality and Disparities Report (NHQDR)
Version 5 4/18/2019 1
Evidence-based Practice Center
Technical Brief Protocol
Project Title: Updating the Measurement Criteria for AHRQ’s
National Healthcare Quality and Disparities Report (NHQDR)
Init…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-radiation_executive.pdf
November 01, 2009 - The number in each cell indicates the total number of studies.